位置:首页 > 蛋白库 > DNM1L_MOUSE
DNM1L_MOUSE
ID   DNM1L_MOUSE             Reviewed;         742 AA.
AC   Q8K1M6; Q8BNQ5; Q8BQ64; Q8CGD0; Q8K1A1;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2005, sequence version 2.
DT   03-AUG-2022, entry version 172.
DE   RecName: Full=Dynamin-1-like protein;
DE            EC=3.6.5.5;
DE   AltName: Full=Dynamin family member proline-rich carboxyl-terminal domain less;
DE            Short=Dymple;
DE   AltName: Full=Dynamin-related protein 1;
GN   Name=Dnm1l; Synonyms=Drp1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Osteoclast;
RX   PubMed=14592431; DOI=10.1016/j.bbrc.2003.10.008;
RA   Honda S., Hirose S.;
RT   "Stage-specific enhanced expression of mitochondrial fusion and fission
RT   factors during spermatogenesis in rat testis.";
RL   Biochem. Biophys. Res. Commun. 311:424-432(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Adipose tissue, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   STRAIN=C57BL/6J; TISSUE=Brain, Mammary gland, and Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 448-659 (ISOFORM 1).
RX   PubMed=11544199; DOI=10.1101/gr.185501;
RA   Piao Y., Ko N.T., Lim M.K., Ko M.S.H.;
RT   "Construction of long-transcript enriched cDNA libraries from submicrogram
RT   amounts of total RNAs by a universal PCR amplification method.";
RL   Genome Res. 11:1553-1558(2001).
RN   [5]
RP   PROTEIN SEQUENCE OF 626-640 AND 725-737, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hippocampus;
RA   Lubec G., Klug S.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=9422767; DOI=10.1074/jbc.273.2.1044;
RA   Kamimoto T., Nagai Y., Onogi H., Muro Y., Wakabayashi T., Hagiwara M.;
RT   "Dymple, a novel dynamin-like high molecular weight GTPase lacking a
RT   proline-rich carboxyl-terminal domain in mammalian cells.";
RL   J. Biol. Chem. 273:1044-1051(1998).
RN   [7]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND CONDITIONAL KNOCKOUT IN PURKINJE CELLS.
RX   PubMed=19752021; DOI=10.1083/jcb.200903065;
RA   Wakabayashi J., Zhang Z., Wakabayashi N., Tamura Y., Fukaya M.,
RA   Kensler T.W., Iijima M., Sesaki H.;
RT   "The dynamin-related GTPase Drp1 is required for embryonic and brain
RT   development in mice.";
RL   J. Cell Biol. 186:805-816(2009).
RN   [8]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=19578372; DOI=10.1038/ncb1907;
RA   Ishihara N., Nomura M., Jofuku A., Kato H., Suzuki S.O., Masuda K.,
RA   Otera H., Nakanishi Y., Nonaka I., Goto Y., Taguchi N., Morinaga H.,
RA   Maeda M., Takayanagi R., Yokota S., Mihara K.;
RT   "Mitochondrial fission factor Drp1 is essential for embryonic development
RT   and synapse formation in mice.";
RL   Nat. Cell Biol. 11:958-966(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-622, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [10]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND CONDITIONAL KNOCKOUT IN PURKINJE CELLS.
RX   PubMed=22564413; DOI=10.1083/jcb.201110034;
RA   Kageyama Y., Zhang Z., Roda R., Fukaya M., Wakabayashi J., Wakabayashi N.,
RA   Kensler T.W., Reddy P.H., Iijima M., Sesaki H.;
RT   "Mitochondrial division ensures the survival of postmitotic neurons by
RT   suppressing oxidative damage.";
RL   J. Cell Biol. 197:535-551(2012).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23283981; DOI=10.1091/mbc.e12-10-0721;
RA   Loson O.C., Song Z., Chen H., Chan D.C.;
RT   "Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial
RT   fission.";
RL   Mol. Biol. Cell 24:659-667(2013).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-603, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, MUTAGENESIS OF THR-59, CATALYTIC ACTIVITY,
RP   AND INTERACTION WITH MIEF1.
RX   PubMed=24508339; DOI=10.1016/j.str.2014.01.001;
RA   Loson O.C., Liu R., Rome M.E., Meng S., Kaiser J.T., Shan S.O., Chan D.C.;
RT   "The mitochondrial fission receptor Mid51 requires ADP as a cofactor.";
RL   Structure 22:367-377(2014).
RN   [14]
RP   FUNCTION.
RX   PubMed=29478834; DOI=10.1016/j.cmet.2018.01.011;
RA   Schmitt K., Grimm A., Dallmann R., Oettinghaus B., Restelli L.M.,
RA   Witzig M., Ishihara N., Mihara K., Ripperger J.A., Albrecht U., Frank S.,
RA   Brown S.A., Eckert A.;
RT   "Circadian control of DRP1 activity regulates mitochondrial dynamics and
RT   bioenergetics.";
RL   Cell Metab. 27:657-666(2018).
RN   [15]
RP   INTERACTION WITH MFF, AND SUBCELLULAR LOCATION.
RX   PubMed=30059978; DOI=10.1210/en.2018-00426;
RA   Lee J., Pappalardo Z., Chopra D.G., Hennings T.G., Vaughn I., Lan C.,
RA   Choe J.J., Ang K., Chen S., Arkin M., McManus M.T., German M.S., Ku G.M.;
RT   "A Genetic Interaction Map of Insulin Production Identifies Mfi as an
RT   Inhibitor of Mitochondrial Fission.";
RL   Endocrinology 159:3321-3330(2018).
RN   [16]
RP   FUNCTION, PHOSPHORYLATION AT SER-622, AND MUTAGENESIS OF SER-622.
RX   PubMed=32484300; DOI=10.15252/embr.201948686;
RA   Han H., Tan J., Wang R., Wan H., He Y., Yan X., Guo J., Gao Q., Li J.,
RA   Shang S., Chen F., Tian R., Liu W., Liao L., Tang B., Zhang Z.;
RT   "PINK1 phosphorylates Drp1S616 to regulate mitophagy-independent
RT   mitochondrial dynamics.";
RL   EMBO Rep. 21:48686-48686(2020).
CC   -!- FUNCTION: Functions in mitochondrial and peroxisomal division
CC       (PubMed:19578372, PubMed:19752021, PubMed:22564413, PubMed:23283981,
CC       PubMed:24508339, PubMed:29478834, PubMed:32484300). Mediates membrane
CC       fission through oligomerization into membrane-associated tubular
CC       structures that wrap around the scission site to constrict and sever
CC       the mitochondrial membrane through a GTP hydrolysis-dependent mechanism
CC       (PubMed:24508339). The specific recruitment at scission sites is
CC       mediated by membrane receptors like MFF, MIEF1 and MIEF2 for
CC       mitochondrial membranes (PubMed:23283981, PubMed:24508339). While the
CC       recruitment by the membrane receptors is GTP-dependent, the following
CC       hydrolysis of GTP induces the dissociation from the receptors and
CC       allows DNM1L filaments to curl into closed rings that are probably
CC       sufficient to sever a double membrane (PubMed:24508339). Acts
CC       downstream of PINK1 to promote mitochondrial fission in a PRKN-
CC       dependent manner (PubMed:32484300). Plays an important role in
CC       mitochondrial fission during mitosis (By similarity). Required for
CC       formation of endocytic vesicles (By similarity). Through its function
CC       in mitochondrial division, ensures the survival of at least some types
CC       of postmitotic neurons, including Purkinje cells, by suppressing
CC       oxidative damage (PubMed:19752021, PubMed:22564413). Required for
CC       normal brain development, including that of cerebellum
CC       (PubMed:19578372, PubMed:22564413). Facilitates developmentally
CC       regulated apoptosis during neural tube formation (PubMed:19578372).
CC       Required for a normal rate of cytochrome c release and caspase
CC       activation during apoptosis; this requirement may depend upon the cell
CC       type and the physiological apoptotic cues (PubMed:19578372). Proposed
CC       to regulate synaptic vesicle membrane dynamics through association with
CC       BCL2L1 isoform Bcl-X(L) which stimulates its GTPase activity in
CC       synaptic vesicles; the function may require its recruitment by MFF to
CC       clathrin-containing vesicles (By similarity). Required for programmed
CC       necrosis execution (By similarity). Rhythmic control of its activity
CC       following phosphorylation at Ser-643 is essential for the circadian
CC       control of mitochondrial ATP production (PubMed:29478834).
CC       {ECO:0000250|UniProtKB:O00429, ECO:0000269|PubMed:19578372,
CC       ECO:0000269|PubMed:19752021, ECO:0000269|PubMed:22564413,
CC       ECO:0000269|PubMed:23283981, ECO:0000269|PubMed:24508339,
CC       ECO:0000269|PubMed:29478834, ECO:0000269|PubMed:32484300}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP + H2O = GDP + H(+) + phosphate; Xref=Rhea:RHEA:19669,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.5;
CC         Evidence={ECO:0000269|PubMed:24508339};
CC   -!- SUBUNIT: Homotetramer; dimerizes through the N-terminal GTP-middle
CC       region of one molecule binding to the GED domain of another DNM1L
CC       molecule. Oligomerizes in a GTP-dependent manner to form membrane-
CC       associated tubules with a spiral pattern. Interacts with GSK3B and
CC       MARCHF5. Interacts (via the GTPase and B domains) with UBE2I; the
CC       interaction promotes sumoylation of DNM1L, mainly in its B domain.
CC       Interacts with PPP3CA; the interaction dephosphorylates DNM1L and
CC       regulates its transition to mitochondria. Interacts with BCL2L1 isoform
CC       BCL-X(L) and CLTA; DNM1L and BCL2L1 isoform BCL-X(L) may form a complex
CC       in synaptic vesicles that also contains clathrin and MFF. Interacts
CC       with MFF; the interaction is inhibited by C11orf65/MFI
CC       (PubMed:30059978). Interacts with FIS1. Interacts with MIEF2 and MIEF1;
CC       GTP-dependent, regulates GTP hydrolysis and DNM1L oligomerization
CC       (PubMed:24508339). Interacts with PGAM5; this interaction leads to
CC       dephosphorylation at Ser-656 and activation of GTPase activity and
CC       eventually to mitochondria fragmentation. Interacts with RALBP1; during
CC       mitosis, recruits DNM1L to the mitochondrion and mediates its
CC       activation by the mitotic kinase cyclin B-CDK1 (By similarity).
CC       {ECO:0000250|UniProtKB:O00429, ECO:0000269|PubMed:24508339,
CC       ECO:0000269|PubMed:30059978}.
CC   -!- INTERACTION:
CC       Q8K1M6; Q925I1: Atad3; NbExp=13; IntAct=EBI-2365792, EBI-772703;
CC       Q8K1M6; Q5S006: Lrrk2; NbExp=5; IntAct=EBI-2365792, EBI-2693710;
CC       Q8K1M6; Q6PCP5: Mff; NbExp=2; IntAct=EBI-2365792, EBI-21985996;
CC       Q8K1M6; Q8BGV8: Mief1; NbExp=2; IntAct=EBI-2365792, EBI-16092561;
CC       Q8K1M6-3; Q8BGV8: Mief1; NbExp=5; IntAct=EBI-16092613, EBI-16092561;
CC       Q8K1M6-3; Q5NCS9: Mief2; NbExp=2; IntAct=EBI-16092613, EBI-16092669;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:30059978}.
CC       Golgi apparatus {ECO:0000250}. Endomembrane system; Peripheral membrane
CC       protein. Mitochondrion outer membrane {ECO:0000269|PubMed:30059978};
CC       Peripheral membrane protein. Peroxisome {ECO:0000250}. Membrane,
CC       clathrin-coated pit {ECO:0000250}. Cytoplasmic vesicle, secretory
CC       vesicle, synaptic vesicle membrane {ECO:0000250}. Note=Mainly
CC       cytosolic. Recruited by RALA and RALBP1 to mitochondrion during mitosis
CC       (By similarity). Translocated to the mitochondrial membrane through O-
CC       GlcNAcylation and interaction with FIS1. Colocalized with MARCHF5 at
CC       mitochondrial membrane. Localizes to mitochondria at sites of division.
CC       Localizes to mitochondria following necrosis induction. Recruited to
CC       the mitochondrial outer membrane by interaction with MIEF1.
CC       Mitochondrial recruitment is inhibited by C11orf65/MFI
CC       (PubMed:30059978). Associated with peroxisomal membranes, partly
CC       recruited there by PEX11B. May also be associated with endoplasmic
CC       reticulum tubules and cytoplasmic vesicles and found to be perinuclear.
CC       In some cell types, localizes to the Golgi complex (By similarity).
CC       Binds to phospholipid membranes. {ECO:0000250,
CC       ECO:0000250|UniProtKB:O00429, ECO:0000269|PubMed:30059978}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8K1M6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8K1M6-2; Sequence=VSP_013695;
CC       Name=3;
CC         IsoId=Q8K1M6-3; Sequence=VSP_013690, VSP_013694;
CC       Name=4;
CC         IsoId=Q8K1M6-4; Sequence=VSP_013689, VSP_013691, VSP_013695;
CC       Name=5;
CC         IsoId=Q8K1M6-5; Sequence=VSP_013690, VSP_013692, VSP_013693;
CC   -!- TISSUE SPECIFICITY: Expressed in the cerebellum and in several regions
CC       of the cerebrum and diencephalon. Strongly expressed in the cerebellar
CC       Purkinje cells and in the pontile giant neurons.
CC       {ECO:0000269|PubMed:9422767}.
CC   -!- DOMAIN: The GED domain folds back to interact, in cis, with the GTP-
CC       binding domain and middle domain, and interacts, in trans, with the GED
CC       domains of other DNM1L molecules, and is thus critical for activating
CC       GTPase activity and for DNM1L dimerization.
CC       {ECO:0000250|UniProtKB:O00429}.
CC   -!- PTM: Phosphorylation/dephosphorylation events on two sites near the GED
CC       domain regulate mitochondrial fission (By similarity). Phosphorylation
CC       on Ser-643 inhibits mitochondrial fission probably through preventing
CC       intramolecular interaction (By similarity). Dephosphorylated on this
CC       site by PPP3CA which promotes mitochondrial fission (By similarity).
CC       Phosphorylation on Ser-622 by Pink1 activates the GTPase activity and
CC       promotes mitochondrial fission (PubMed:32484300). Phosphorylated in a
CC       circadian manner at Ser-643 (By similarity).
CC       {ECO:0000250|UniProtKB:O00429, ECO:0000269|PubMed:32484300}.
CC   -!- PTM: Sumoylated on various lysine residues within the B domain,
CC       probably by MUL1. Sumoylation positively regulates mitochondrial
CC       fission. Desumoylated by SENP5 during G2/M transition of mitosis.
CC       Appears to be linked to its catalytic activity (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: S-nitrosylation increases DNM1L dimerization, mitochondrial
CC       fission and causes neuronal damage. {ECO:0000250}.
CC   -!- PTM: O-GlcNAcylation augments the level of the GTP-bound active form of
CC       DNM1L and induces translocation from the cytoplasm to mitochondria in
CC       cardiomyocytes. It also decreases phosphorylation at Ser-643 (By
CC       similarity). {ECO:0000250|UniProtKB:O35303}.
CC   -!- PTM: Ubiquitination by MARCHF5 affects mitochondrial morphology.
CC       {ECO:0000250|UniProtKB:O00429}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice show severe developmental
CC       abnormalities and die between 10.5 and 12.5 dpc. Compared to wild-type
CC       littermates, mutant embryos at 9.5-11.5 dpc have a significantly
CC       smaller body size, pulsing, but less developed cardiac structures, a
CC       poorly developed liver and a thinner neural tube cell layer. They lack
CC       trophoblastic giant cell layer in the placenta. Primary cultures of
CC       mutant neuronal cells have severe defects in synapse formation and high
CC       sensitivity to Ca(2+)-dependent apoptosis. Within cerebellar neurons,
CC       Purkinje cells are particularly sensitive to Dnm1l ablation.
CC       Conditional knockout in postmitotic Purkinje cells leads to 40%
CC       neuronal degeneration after 3 months and 90% after 6 months.
CC       {ECO:0000269|PubMed:19578372, ECO:0000269|PubMed:19752021,
CC       ECO:0000269|PubMed:22564413}.
CC   -!- SIMILARITY: Belongs to the TRAFAC class dynamin-like GTPase
CC       superfamily. Dynamin/Fzo/YdjA family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01055}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB079133; BAC06576.1; -; mRNA.
DR   EMBL; AK051443; BAC34640.1; -; mRNA.
DR   EMBL; AK080871; BAC38054.1; -; mRNA.
DR   EMBL; BC027538; AAH27538.1; -; mRNA.
DR   EMBL; BC040777; AAH40777.1; -; mRNA.
DR   EMBL; BC079635; AAH79635.1; -; mRNA.
DR   EMBL; CF914619; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS27984.1; -. [Q8K1M6-3]
DR   CCDS; CCDS70689.1; -. [Q8K1M6-2]
DR   CCDS; CCDS88885.1; -. [Q8K1M6-4]
DR   RefSeq; NP_001021118.1; NM_001025947.2. [Q8K1M6-3]
DR   RefSeq; NP_001263269.1; NM_001276340.1. [Q8K1M6-2]
DR   RefSeq; NP_001263270.1; NM_001276341.1. [Q8K1M6-4]
DR   RefSeq; NP_690029.2; NM_152816.3.
DR   RefSeq; XP_006522694.1; XM_006522631.3. [Q8K1M6-1]
DR   AlphaFoldDB; Q8K1M6; -.
DR   SMR; Q8K1M6; -.
DR   BioGRID; 216417; 25.
DR   CORUM; Q8K1M6; -.
DR   DIP; DIP-54818N; -.
DR   IntAct; Q8K1M6; 34.
DR   MINT; Q8K1M6; -.
DR   STRING; 10090.ENSMUSP00000111415; -.
DR   ChEMBL; CHEMBL2331072; -.
DR   GlyGen; Q8K1M6; 2 sites.
DR   iPTMnet; Q8K1M6; -.
DR   PhosphoSitePlus; Q8K1M6; -.
DR   SwissPalm; Q8K1M6; -.
DR   EPD; Q8K1M6; -.
DR   jPOST; Q8K1M6; -.
DR   MaxQB; Q8K1M6; -.
DR   PeptideAtlas; Q8K1M6; -.
DR   PRIDE; Q8K1M6; -.
DR   ProteomicsDB; 277358; -. [Q8K1M6-1]
DR   ProteomicsDB; 277359; -. [Q8K1M6-2]
DR   ProteomicsDB; 277360; -. [Q8K1M6-3]
DR   ProteomicsDB; 277361; -. [Q8K1M6-4]
DR   ProteomicsDB; 277362; -. [Q8K1M6-5]
DR   Antibodypedia; 4096; 729 antibodies from 38 providers.
DR   DNASU; 74006; -.
DR   Ensembl; ENSMUST00000023477; ENSMUSP00000023477; ENSMUSG00000022789. [Q8K1M6-3]
DR   Ensembl; ENSMUST00000230022; ENSMUSP00000155429; ENSMUSG00000022789. [Q8K1M6-4]
DR   Ensembl; ENSMUST00000230038; ENSMUSP00000155605; ENSMUSG00000022789. [Q8K1M6-5]
DR   Ensembl; ENSMUST00000230980; ENSMUSP00000155155; ENSMUSG00000022789. [Q8K1M6-2]
DR   GeneID; 74006; -.
DR   KEGG; mmu:74006; -.
DR   UCSC; uc007yij.2; mouse. [Q8K1M6-1]
DR   UCSC; uc007yik.2; mouse. [Q8K1M6-4]
DR   UCSC; uc007yim.2; mouse. [Q8K1M6-3]
DR   UCSC; uc007yin.2; mouse. [Q8K1M6-2]
DR   UCSC; uc007yio.2; mouse. [Q8K1M6-5]
DR   CTD; 10059; -.
DR   MGI; MGI:1921256; Dnm1l.
DR   VEuPathDB; HostDB:ENSMUSG00000022789; -.
DR   eggNOG; KOG0446; Eukaryota.
DR   GeneTree; ENSGT00940000155504; -.
DR   HOGENOM; CLU_008964_5_0_1; -.
DR   InParanoid; Q8K1M6; -.
DR   OrthoDB; 264244at2759; -.
DR   PhylomeDB; Q8K1M6; -.
DR   TreeFam; TF352031; -.
DR   BRENDA; 3.6.5.5; 3474.
DR   Reactome; R-MMU-75153; Apoptotic execution phase.
DR   BioGRID-ORCS; 74006; 27 hits in 75 CRISPR screens.
DR   ChiTaRS; Dnm1l; mouse.
DR   PRO; PR:Q8K1M6; -.
DR   Proteomes; UP000000589; Chromosome 16.
DR   RNAct; Q8K1M6; protein.
DR   Bgee; ENSMUSG00000022789; Expressed in ventral tegmental area and 254 other tissues.
DR   ExpressionAtlas; Q8K1M6; baseline and differential.
DR   Genevisible; Q8K1M6; MM.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0005905; C:clathrin-coated pit; ISO:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR   GO; GO:0000139; C:Golgi membrane; ISO:MGI.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; ISO:MGI.
DR   GO; GO:0031966; C:mitochondrial membrane; ISO:MGI.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0099073; C:mitochondrion-derived vesicle; ISO:MGI.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0005777; C:peroxisome; ISS:UniProtKB.
DR   GO; GO:0098835; C:presynaptic endocytic zone membrane; ISO:MGI.
DR   GO; GO:0032991; C:protein-containing complex; ISO:MGI.
DR   GO; GO:0099503; C:secretory vesicle; ISO:MGI.
DR   GO; GO:0030672; C:synaptic vesicle membrane; ISO:MGI.
DR   GO; GO:0051433; F:BH2 domain binding; ISO:MGI.
DR   GO; GO:0030276; F:clathrin binding; ISO:MGI.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0030742; F:GTP-dependent protein binding; ISO:MGI.
DR   GO; GO:0003924; F:GTPase activity; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; ISO:MGI.
DR   GO; GO:0031267; F:small GTPase binding; ISO:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0006816; P:calcium ion transport; IMP:MGI.
DR   GO; GO:0090650; P:cellular response to oxygen-glucose deprivation; IEA:Ensembl.
DR   GO; GO:1904579; P:cellular response to thapsigargin; ISO:MGI.
DR   GO; GO:0003374; P:dynamin family protein polymerization involved in mitochondrial fission; ISS:UniProtKB.
DR   GO; GO:0060047; P:heart contraction; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0048312; P:intracellular distribution of mitochondria; ISO:MGI.
DR   GO; GO:0061025; P:membrane fusion; ISO:MGI.
DR   GO; GO:0000266; P:mitochondrial fission; IMP:UniProtKB.
DR   GO; GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; ISO:MGI.
DR   GO; GO:0090149; P:mitochondrial membrane fission; ISO:MGI.
DR   GO; GO:0070584; P:mitochondrion morphogenesis; ISO:MGI.
DR   GO; GO:0007005; P:mitochondrion organization; IMP:MGI.
DR   GO; GO:0070266; P:necroptotic process; IMP:UniProtKB.
DR   GO; GO:0010637; P:negative regulation of mitochondrial fusion; ISO:MGI.
DR   GO; GO:0016559; P:peroxisome fission; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISO:MGI.
DR   GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISO:MGI.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISO:MGI.
DR   GO; GO:0090141; P:positive regulation of mitochondrial fission; ISO:MGI.
DR   GO; GO:0090023; P:positive regulation of neutrophil chemotaxis; ISO:MGI.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:MGI.
DR   GO; GO:0090200; P:positive regulation of release of cytochrome c from mitochondria; ISO:MGI.
DR   GO; GO:1900244; P:positive regulation of synaptic vesicle endocytosis; ISO:MGI.
DR   GO; GO:2000302; P:positive regulation of synaptic vesicle exocytosis; ISO:MGI.
DR   GO; GO:0051259; P:protein complex oligomerization; ISS:UniProtKB.
DR   GO; GO:0070585; P:protein localization to mitochondrion; IMP:MGI.
DR   GO; GO:0065003; P:protein-containing complex assembly; ISO:MGI.
DR   GO; GO:1903578; P:regulation of ATP metabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1903146; P:regulation of autophagy of mitochondrion; ISO:MGI.
DR   GO; GO:0010468; P:regulation of gene expression; IMP:MGI.
DR   GO; GO:0010821; P:regulation of mitochondrion organization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1900063; P:regulation of peroxisome organization; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1904666; P:regulation of ubiquitin protein ligase activity; IMP:MGI.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; ISO:MGI.
DR   GO; GO:1905395; P:response to flavonoid; IEA:Ensembl.
DR   GO; GO:1990910; P:response to hypobaric hypoxia; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISO:MGI.
DR   GO; GO:0036466; P:synaptic vesicle recycling via endosome; ISO:MGI.
DR   CDD; cd08771; DLP_1; 1.
DR   Gene3D; 3.40.50.300; -; 1.
DR   InterPro; IPR030556; DNM1L.
DR   InterPro; IPR022812; Dynamin.
DR   InterPro; IPR001401; Dynamin_GTPase.
DR   InterPro; IPR019762; Dynamin_GTPase_CS.
DR   InterPro; IPR045063; Dynamin_N.
DR   InterPro; IPR000375; Dynamin_stalk.
DR   InterPro; IPR030381; G_DYNAMIN_dom.
DR   InterPro; IPR003130; GED.
DR   InterPro; IPR020850; GED_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR11566; PTHR11566; 1.
DR   PANTHER; PTHR11566:SF39; PTHR11566:SF39; 1.
DR   Pfam; PF01031; Dynamin_M; 1.
DR   Pfam; PF00350; Dynamin_N; 1.
DR   Pfam; PF02212; GED; 1.
DR   PRINTS; PR00195; DYNAMIN.
DR   SMART; SM00053; DYNc; 1.
DR   SMART; SM00302; GED; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00410; G_DYNAMIN_1; 1.
DR   PROSITE; PS51718; G_DYNAMIN_2; 1.
DR   PROSITE; PS51388; GED; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Biological rhythms; Coated pit;
KW   Cytoplasm; Cytoplasmic vesicle; Direct protein sequencing; Endocytosis;
KW   Glycoprotein; Golgi apparatus; GTP-binding; Hydrolase; Isopeptide bond;
KW   Lipid-binding; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Necrosis; Nucleotide-binding; Peroxisome; Phosphoprotein;
KW   Reference proteome; S-nitrosylation; Synapse; Ubl conjugation.
FT   CHAIN           1..742
FT                   /note="Dynamin-1-like protein"
FT                   /id="PRO_0000206567"
FT   DOMAIN          22..308
FT                   /note="Dynamin-type G"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   DOMAIN          650..741
FT                   /note="GED"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00720"
FT   REGION          32..39
FT                   /note="G1 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          58..60
FT                   /note="G2 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          152..155
FT                   /note="G3 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          221..224
FT                   /note="G4 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          251..254
FT                   /note="G5 motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01055"
FT   REGION          350..495
FT                   /note="Middle domain"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   REGION          454..691
FT                   /note="Interaction with GSK3B"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   REGION          508..575
FT                   /note="B domain"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   REGION          528..560
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          548..742
FT                   /note="C-terminal dimerization domain"
FT                   /evidence="ECO:0000250"
FT   REGION          572..594
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          660..674
FT                   /note="Important for homodimerization"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   BINDING         32..40
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   BINDING         221..227
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   BINDING         252..255
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   MOD_RES         535
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   MOD_RES         603
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         613
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   MOD_RES         622
FT                   /note="Phosphoserine; by PINK1"
FT                   /evidence="ECO:0000269|PubMed:32484300,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         643
FT                   /note="Phosphoserine; by CAMK1 and PKA"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   MOD_RES         650
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:O00429"
FT   CARBOHYD        591
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        592
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        538
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        541
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        564
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        574
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        600
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        603
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        612
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        614
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..104
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013689"
FT   VAR_SEQ         85..90
FT                   /note="Missing (in isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_013690"
FT   VAR_SEQ         105
FT                   /note="K -> M (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013691"
FT   VAR_SEQ         214..227
FT                   /note="RRTLAVITKLDLMD -> KGRCLYLMDVDLQW (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_013692"
FT   VAR_SEQ         228..742
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_013693"
FT   VAR_SEQ         539..575
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:16141072"
FT                   /id="VSP_013694"
FT   VAR_SEQ         539..564
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14592431,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_013695"
FT   MUTAGEN         59
FT                   /note="T->A: Abolishes GTP hydrolysis."
FT                   /evidence="ECO:0000269|PubMed:24508339"
FT   MUTAGEN         622
FT                   /note="S->A: Loss of activity and phosphorylation. Unable
FT                   to rescue aberrant mitochondrial fission in PINK1 null
FT                   mutant neurons."
FT                   /evidence="ECO:0000269|PubMed:32484300"
FT   CONFLICT        165
FT                   /note="P -> L (in Ref. 1; BAC06576)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320
FT                   /note="Q -> R (in Ref. 1; BAC06576)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        519
FT                   /note="E -> A (in Ref. 2; BAC34640)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   742 AA;  82658 MW;  5A8679B61A444847 CRC64;
     MEALIPVINK LQDVFNTVGA DIIQLPQIVV VGTQSSGKSS VLESLVGRDL LPRGTGVVTR
     RPLILQLVHV SPEDKRKTTG EENGKFQSWR VEAEEWGKFL HTKNKLYTDF DEIRQEIENE
     TERISGNNKG VSPEPIHLKV FSPNVVNLTL VDLPGMTKVP VGDQPKDIEL QIRELILRFI
     SNPNSIILAV TAANTDMATS EALKISREVD PDGRRTLAVI TKLDLMDAGT DAMDVLMGRV
     IPVKLGIIGV VNRSQLDINN KKSVTDSIRD EYAFLQKKYP SLANRNGTKY LARTLNRLLM
     HHIRDCLPEL KTRINVLAAQ YQSLLNSYGE PVDDKSATLL QLITKFATEY CNTIEGTAKY
     IETSELCGGA RICYIFHETF GRTLESVDPL GGLNTIDILT AIRNATGPRP ALFVPEVSFE
     LLVKRQIKRL EEPSLRCVEL VHEEMQRIIQ HCSNYSTQEL LRFPKLHDAI VEVVTCLLRK
     RLPVTNEMVH NLVAIELAYI NTKHPDFADA CGLMNNNIEE QRRNRLAREL PSAGSRDKSS
     KVPSALAPAS QEPPPAASAE ADGKLIQDNR RETKNVPSAG GGIGDGGQEP TTGNWRGMLK
     TSKAEELLAE EKSKPIPIMP ASPQKGHAVN LLDVPVPVAR KLSAREQRDC EVIERLIKSY
     FLIVRKNIQD SVPKAVMHFL VNHVKDTLQS ELVGQLYKSS LLDDLLTESE DMAQRRKEAA
     DMLKALQGAS QIIAEIRETH LW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024